TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22424877

Group type: EXPERIMENTAL
Intervention: Warmth exposure
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sucrose taste
Number of subjects: 47

Group type: COMPARATOR
Intervention: Pacifier suckling
Number of subjects: 47
Study: 20339833

Group type: EXPERIMENTAL
Intervention: Solifenacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18064446

Group type: EXPERIMENTAL
Intervention: Antioxidants (Nature Made R) given 2 hours before ESWL, and 2 and 8 hours after ESWL (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antioxidants (Nature Made R) given 2 and 8 hours after ESWL (Group C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No antioxidants (Control Group A)
Number of subjects: 120
Study: 16055569

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine continuous wound infusion
Number of subjects: 79

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 79
Study: 12658791

Group type: EXPERIMENTAL
Intervention: BCG-PSN
Number of subjects: 0
Study: 10512925

Group type: EXPERIMENTAL
Intervention: MTHFR A677V allele in patients with CAS
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control subjects without CAS
Number of subjects: 48
Study: 7574757

Group type: EXPERIMENTAL
Intervention: Combined treatments (preoperative hyperthermia, irradiation, 5-fluorouracil suppository)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 31
Study: 1701742

Group type: EXPERIMENTAL
Intervention: Home assessment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Clinic assessment
Number of subjects: 50
Study: 458602

Group type: EXPERIMENTAL
Intervention: Benoxaprofen with crystals smaller than 100 mesh (mean equivalent spherical diameter = 67 micron)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Benoxaprofen with crystals larger than 60 mesh (mean equivalent spherical diameter = 640 micron)
Number of subjects: 10
Study: 31352906

Group type: EXPERIMENTAL
Intervention: Plasma retinol levels (per 10 μg/dl increases)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Quartile 2-4 retinol levels (≥ 52.3 μg/dl) compared to quartile 1 (< 52.3 μg/dl)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Plasma retinol levels (per 10 μg/dl increases) in participants with retinol < 68.2 μg/dl
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Plasma retinol levels (per 10 μg/dl increases) in participants with retinol ≥ 68.2 μg/dl
Number of subjects: 462
Study: 29474547

Group type: EXPERIMENTAL
Intervention: Substance use treatment and trauma symptom management
Number of subjects: 7
Study: 26669430

Group type: EXPERIMENTAL
Intervention: 800 mg of Ca (2·4 g Aquamin)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 800 mg of Ca with 3 g of scFOS
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (maltodextrin)
Number of subjects: 300
Study: 24631278

Group type: EXPERIMENTAL
Intervention: Cryotherapy (ice, cold water at ∼11°C)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (tepid water at ∼26°C)
Number of subjects: 26
Study: 22621166

Group type: EXPERIMENTAL
Intervention: G79 (primer application + heat treatment at 79°C) without aging
Number of subjects: 14

Group type: COMPARATOR
Intervention: GC (control, without primer)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: G20 (primer application at ambient temperature 20°C)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: G100 (primer application + heat treatment at 100°C)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: G45 (primer application + heat treatment at 45°C)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Aging groups (all experimental groups)
Number of subjects: 14
Study: 20954960

Group type: EXPERIMENTAL
Intervention: Slow abdominal breathing combined with EMG biofeedback training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Slow abdominal breathing
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: AB+BF group (slow abdominal breathing + EMG biofeedback)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 22
Study: 17388962

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diet (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 40
Study: 16322134

Group type: EXPERIMENTAL
Intervention: Modafinil (170-425 mg once daily)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 248
Study: 12224807

Group type: EXPERIMENTAL
Intervention: Intentional processing of frequency
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unintentional processing of frequency
Number of subjects: 0
Study: 11605079

Group type: EXPERIMENTAL
Intervention: d-amphetamine sulfate (10 mg and 20 mg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: bupropion hydrochloride (150 mg and 300 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 9581412

Group type: EXPERIMENTAL
Intervention: Round 2-mm-diameter bar with clips
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ball attachments (Nobel Biocare)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both attachment systems
Number of subjects: 50
Study: 7921524

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 3395543

Group type: EXPERIMENTAL
Intervention: Trans-arterial technique
Number of subjects: 2

Group type: COMPARATOR
Intervention: Winnie technique
Number of subjects: 2
Study: 4553818

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (AMCA, Cyclokapron), 1 g three times a day for five days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31005246

Group type: EXPERIMENTAL
Intervention: Osteopathy (arm B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard analgesic treatment (arm A)
Number of subjects: 80
Study: 28054262

Group type: EXPERIMENTAL
Intervention: PBMT
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CPG
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PCG
Number of subjects: 40

Group type: COMPARATOR
Intervention: CG
Number of subjects: 40

Group type: COMPARATOR
Intervention: PG
Number of subjects: 40
Study: 25303170

Group type: EXPERIMENTAL
Intervention: 5 minutes of self‐selected music (pre‐task music condition)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 5 minutes of silence (control condition)
Number of subjects: 18
Study: 23731284

Group type: EXPERIMENTAL
Intervention: ICD deactivation (Group 1)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No ICD deactivation with hospice or DNR orders (Group 2)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No ICD deactivation without hospice or DNR orders (Group 3)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: ICD shocks in the last week before death
Number of subjects: 98
Study: 22042959

Group type: EXPERIMENTAL
Intervention: Survivorship care plan (SCP) reviewed during a 30-minute educational session with a nurse; PCP received the SCP and guideline on follow-up.
Number of subjects: 408

Group type: COMPARATOR
Intervention: Standard discharge visit with the oncologist (control group).
Number of subjects: 408
Study: 19505775

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (KC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Incubator Care (IC)
Number of subjects: 14
Study: 17011409

Group type: EXPERIMENTAL
Intervention: Faropenem medoxomil 300 mg twice daily for 7 days
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Faropenem medoxomil 300 mg twice daily for 10 days
Number of subjects: 1099

Group type: COMPARATOR
Intervention: Cefuroxime axetil 250 mg twice daily for 10 days
Number of subjects: 1099
Study: 15301792

Group type: EXPERIMENTAL
Intervention: Tension-free method using polypropylene mesh (Group A)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Andrews technique (Group B)
Number of subjects: 34
Study: 11402108

Group type: EXPERIMENTAL
Intervention: IV immunoglobulin (IVIg) 0.4 g/kg daily for 5 days followed by three single infusions monthly for 3 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: IV immunoglobulin (IVIg)
Number of subjects: 55
Study: 9167925

Group type: EXPERIMENTAL
Intervention: Soft (Jones) dressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Short leg cast
Number of subjects: 60
Study: 8461219

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 3026294

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (25 mg twice daily)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg twice daily)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide plus Enalapril
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination treatment (Hydrochlorothiazide plus Enalapril)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 21
Study: 31750225

Group type: EXPERIMENTAL
Intervention: Endoscopic underlay myringoplasty without gelfoam
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endoscopic underlay myringoplasty with gelfoam
Number of subjects: 80
Study: 29291887

Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel
Number of subjects: 7554

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 7554
Study: 24100256

Group type: EXPERIMENTAL
Intervention: Remifentanil target-controlled infusion
Number of subjects: 70

Group type: COMPARATOR
Intervention: Dexmedetomidine single-dose administration (0.5 μg/kg given 10 minutes before the end of surgery)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Dexmedetomidine single-dose administration
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 25272534

Group type: EXPERIMENTAL
Intervention: 2% Diltiazem gel applied twice daily for two weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.2% Glyceryl TriNitrate applied three times a day for two weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cost of treatment
Number of subjects: 60
Study: 22865489

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine plus meperidine (RM Group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: 0.75% ropivacaine (R Group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline (C Group)
Number of subjects: 53
Study: 20682156

Group type: EXPERIMENTAL
Intervention: Dobutamine 5 microg*kg(‐1). min(‐1) (n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Milrinone 0.5 microg*kg(‐1)*min(‐1) (n = 10)
Number of subjects: 20
Study: 17414607

Group type: EXPERIMENTAL
Intervention: Preoperative hepatic and regional arterial chemotherapy (PHRAC)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control (surgery alone)
Number of subjects: 222
Study: 15781429

Group type: EXPERIMENTAL
Intervention: FENO+EZE
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: FENO
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: EZE
Number of subjects: 625

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 625
Study: 14623690

Group type: EXPERIMENTAL
Intervention: Long-pulse 532-nm Nd:YAG laser treatment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 7
Study: 10621853

Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin gel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin gel after placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: bcl-2 positivity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: apoptotic bodies
Number of subjects: 10
Study: 8961487

Group type: EXPERIMENTAL
Intervention: Sequential alternating chemotherapy (Adriamycin/cisplatin and bleomycin/vinblastine; 8.5 +/- 5 cycles)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard PEB chemotherapy (cisplatinum/etoposide/bleomycin; 5.7 +/- 2.1 cycles)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Retroperitoneal lymph node dissection (RPLND) after chemotherapy
Number of subjects: 123
Study: 1809531

Group type: EXPERIMENTAL
Intervention: 4 basic chemicals (imipramine, norephedrine, nicotine, 8-aminoquinoline) applied via a 24-hour patch
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 16
Study: 7073415

Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride (15, 20, and 30 g/day)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Clofibrate (2.0 g/day)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride
Number of subjects: 245
Study: 2867731

Group type: EXPERIMENTAL
Intervention: Diflunisal (DFL)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Dextropropoxyphene napsylate (DPN)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Diflunisal (DFL) and Dextropropoxyphene napsylate (DPN)
Number of subjects: 43
Study: 29653915

Group type: EXPERIMENTAL
Intervention: RUSF (ready-to-use supplementary food)
Number of subjects: 1805

Group type: COMPARATOR
Intervention: no-RUSF
Number of subjects: 1805

Group type: EXPERIMENTAL
Intervention: RUSF
Number of subjects: 1805
Study: 27351320

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg daily
Number of subjects: 198

Group type: COMPARATOR
Intervention: Lactose tablets (Control)
Number of subjects: 198
Study: 25063013

Group type: EXPERIMENTAL
Intervention: 70% ethanol locks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Heparinized saline
Number of subjects: 85
Study: 22107266

Group type: EXPERIMENTAL
Intervention: Preseasonal rush immunotherapy using depigmented polymerized allergenic extract of mixed grass pollen
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 20507672

Group type: EXPERIMENTAL
Intervention: Urban group
Number of subjects: 7049

Group type: EXPERIMENTAL
Intervention: Migrant group
Number of subjects: 7049

Group type: COMPARATOR
Intervention: Rural group
Number of subjects: 7049

Group type: EXPERIMENTAL
Intervention: Western food consumption
Number of subjects: 7049
Study: 18285432

Group type: EXPERIMENTAL
Intervention: Multiple-task training for 30 minutes once a week during the three-week training phase
Number of subjects: 5

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 5
Study: 16174117

Group type: COMPARATOR
Intervention: Low-stress group (Group A) with LV-SWS of 92.0 ± 18.0 mmHg/cm2
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High-stress group (Group B) with LV-SWS of 134.2 ± 32.3 mmHg/cm2
Number of subjects: 38
Study: 11802108

Group type: EXPERIMENTAL
Intervention: Terbinafine (250 mg)
Number of subjects: 24
Study: 10197230

Group type: EXPERIMENTAL
Intervention: Inhaled lignocaine 40 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Inhaled lignocaine 160 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salbutamol pretreatment with lignocaine
Number of subjects: 20
Study: 8116726

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3291558

Group type: EXPERIMENTAL
Intervention: Metoprolol (mean dose 197 mg/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Atenolol (mean dose 86 mg/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Propranolol (mean dose 305 mg/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 30595565

Group type: EXPERIMENTAL
Intervention: Ergocalciferol (50,000 IU weekly) with calcitriol (0.25 mg/d) for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27488472

Group type: EXPERIMENTAL
Intervention: belimumab 10 mg/kg + standard of care (SoC)
Number of subjects: 834

Group type: COMPARATOR
Intervention: placebo + standard of care (SoC)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: belimumab 10 mg/kg + steroids only
Number of subjects: 834

Group type: COMPARATOR
Intervention: placebo + steroids only
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: belimumab 10 mg/kg + steroids + AM
Number of subjects: 834

Group type: COMPARATOR
Intervention: placebo + steroids + AM
Number of subjects: 834
Study: 24643443

Group type: EXPERIMENTAL
Intervention: Educational intervention (distribution and free access to educational study materials)
Number of subjects: 0
Study: 21962976

Group type: EXPERIMENTAL
Intervention: Bifrontal tDCS (1.5 mA for 20 minutes)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bioccipital tDCS (1.5 mA for 20 minutes)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 17
Study: 20021997

Group type: EXPERIMENTAL
Intervention: Levetiracetam (n = 111)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo (n = 106)
Number of subjects: 217
Study: 17932136

Group type: EXPERIMENTAL
Intervention: ATP infusion (80 mug (kg body mass)(‐1) min(‐1))
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no ATP infusion)
Number of subjects: 8
Study: 16273792

Group type: EXPERIMENTAL
Intervention: Disease Activity Score (DAS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EULAR response criteria
Number of subjects: 0
Study: 12108801

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 228

Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 228
Study: 9475565

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate double-strength 84 microg (5 puffs BID)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate regular-strength 42 microg (10 puffs BID)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Oral prednisone 10 mg once a day
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo inhaler
Number of subjects: 64
Study: 8523629

Group type: EXPERIMENTAL
Intervention: Growth hormone, glutamine, and a modified high-carbohydrate, high-fiber diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Modified diet alone
Number of subjects: 10
Study: 2229457

Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 589075

Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Vaginal examination with sweeping of the fetal membranes
Number of subjects: 3

Group type: COMPARATOR
Intervention: Vaginal examination without sweeping of the membranes
Number of subjects: 3
Study: 30687994

Group type: EXPERIMENTAL
Intervention: diacerein 100 mg/day
Number of subjects: 69

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 69
Study: 29668746

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (specifics not provided)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Healthy controls (no intervention)
Number of subjects: 209
Study: 27102407

Group type: EXPERIMENTAL
Intervention: Workplace environmental dietary modification intervention
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Combination of workplace environmental dietary modification and educational intervention
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control workplace
Number of subjects: 4
Study: 25715572

Group type: EXPERIMENTAL
Intervention: Iontophoresis (20 procedures, 20 minutes each)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magnetic field (20 procedures, 30 minutes each)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of iontophoresis and magnetic field (20 procedures)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 60
Study: 21531481

Group type: EXPERIMENTAL
Intervention: HiDHA supplementation (1000 mg of tuna oil; comprising 252 mg DHA, 60 mg EPA and 10 mg vitamin E)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (1000 mg soybean oil)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HiDHA supplementation
Number of subjects: 74
Study: 20679736

Group type: EXPERIMENTAL
Intervention: Adaptive servo ventilation (ASV)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non-ASV (control group)
Number of subjects: 17
Study: 17711912

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise (PRE)
Number of subjects: 22
Study: 16376751

Group type: EXPERIMENTAL
Intervention: Regular hemodialysis (H/D)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal LV systolic function (control group)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Abnormal LV systolic function
Number of subjects: 54
Study: 12212785

Group type: EXPERIMENTAL
Intervention: E2 (estradiol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10030765

Group type: EXPERIMENTAL
Intervention: Ropinirole plus L-dopa
Number of subjects: 30

Group type: COMPARATOR
Intervention: L-dopa
Number of subjects: 30
Study: 7573879

Group type: EXPERIMENTAL
Intervention: Caudal block using 0.125% bupivacaine with adrenaline
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Caudal block using 0.125% bupivacaine with adrenaline + rectally administered diclofenac 1 mg.kg‐1
Number of subjects: 39
Study: 2344682

Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg orally
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 88732

Group type: EXPERIMENTAL
Intervention: BACO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SAKK
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BACO and SAKK
Number of subjects: 0